- Fee assured
- Verified this account
You'll need to contact this healthcare professional to check their availability
I am a consultant neurologist. I diagnose and treat people with any neurological disorder, that is symptoms or conditions affecting the brain, the spinal cord, the nerves and muscles.
I diagnose and treat patients with the common neurological conditions such as headache and migraine, faints and fits, tremors, dizziness, loss of balance, memory loss, tingling, numbness, weakness.
I have a special interest in immune disorders of the nervous system; general neuroimmunology and myasthenia gravis in particular.
Areas of interest
General Neurology; headache; migraine; faints; fits; tremors; dizziness; loss of balance; memory loss; tingling; numbness; weakness. Immune disorders of the nervous system; myasthenia gravis clinics.
Current NHS consultant posts held
I am a consultant Neurologist and Clinical Director of Medical Neurosciences at the Manchester Centre for clinical Neuroscience at Salford Royal Foundation Trust.
I also practice at Wythenshawe Hospital, where my clinics are held at Withington Community Hospital.
Myasthenia Gravis, Neurological aspects of general medical disease, Design of effective services, Musician’s hand disorders.
When the Mancunian weather is acceptable, I run, cycle and walk on the hills and try to maintain a kitchen garden. At other times I try to learn to play the piano.
2010 European Federation of Neurological Societies Investigation Prize awarded to peripheral nerve team at Greater Manchester Neuroscience Centre.
2007 Health Services Journal award for Clinical Service Redesign for Neurological ICATs.
1997 Liversedge Prize awarded by the North of England Neurological Society.
1995 European Neurological Society prize for best scientific paper presented.
1993 Liversedge Prize awarded by the North of England Neurological Society.
Neurological Manifestations of Haematological Disease. J.D.Sussman, G.A.B. Davies-Jones. Neurology in General Medicine, 5th. Edition, Ed. Aminoff, M.
Bulbar myasthenia gravis: Why are treatable patients needing admission to hospital - Are neurologists doing something wrong? Niestrata-Ortiz M.; Sussman J., Niestrata-Ortiz. European Journal of Neurology 2014; 2141
Antisense Treatment for Myasthenia Gravis: Experience with Monarsen J.D. Sussman, Z. Argov, D. McKee, E. Hazum, S. Brawer, H. Soreq. Annals of the New York Academy of Sciences 2012;1275:13-16
Gregersen PK, Kosoy R, Lee AT, Lamb J, Sussman J, et al. Risk for myasthenia gravis maps to a 151Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08. Annals of Neurology 2012. 72:927-935
Argov, Z., McKee, D., Agus, S., Soreq, H., Ben-Joseph, O., Brawer, S., Sussman, J.D. Oral antisense therapy for acetylcholinesterase suppression in myasthena gravis: Preliminary data on efficacy and safety. Neurology 2007;69:699-700
Cytokine regulation of MCP-1 expression in brain and retinal microvascular endothelial cells. K.A. Harkness, J. D. Sussman, G. A. B. Davies-Jones, J. Greenwoode and M. N. Woodroofe. J Neuroimmunology 2003; 142:1-9
Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. K. A. Harkness, J. Greenwood, J. D. Sussman, et al. Brain 2000;123:698-709
Benign Intracranial Hypertension. Sussman JD Sarkies N, Pickard JD. Advances Tech Standards Neurosurg, Springer-Verlag, 1998;24:261-305
Glial lineages and myelination in the central nervous system.
D.A.S. Compston, J. Zajicek, J. Sussman, et al. J Anatomy 1997. 190: 161-200
Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension. J. Sussman, M. Leach, R. Malia, et al. Journal of Neurology, Neurosurgery and Psychiatry 1997. 62: 229-233
Failure to achieve remyelination of demyelinated rat axons following transplant of glial cells obtained from adult human brain. M.P. Targett, J. Sussman, N.J. Scolding, et al. Neuropath Appl Neurobiol 1996. 22: 199-206
A proliferative adult human oligodendrocyte progenitor. N.J. Scolding, P.J. Rayner, J. Sussman, et al. NeuroReport. 1995;6:441-445.
Transplantation of human oligodendrocytes into demyelinating lesions in the rat spinal cord. M.P. Targett, J.D. Sussman, M.T. O’Leary, et al. Neuropathology and Applied Neurobiology, 1995; 21: 446.
Courses offered to GPs
I am always happy to speak to GPs on any common area in General Neurology, either delivering a talk, or an informal discussion based on case histories provided by GPs.
I undergo an Equiniti 360 degree patient feedback assessment every 3 years.
- MB ChB Leeds 1986
- MRCP (UK) Royal College of Physicians (London) 1989
- PhD University of Cambridge 1998
- FRCP Royal College of Physicians (London) 2001
- CCST Neurology Royal College of Physicians (London) 1998
Reference number 3139415
Professional bodies (positions held - last 3 yrs)
- Member Association of British Neurologists 1998
- Member American Academy of Neurology 2008
- Assistant (meetings) Secretary Association of British Neurologists 2017
Details of entry to specialist register
- CCST Neurology, 1998
- BMI The Alexandra Hospital, SK8 2PX
- 14:00 - 17:00
- 0161 428 3656
- BMI The Alexandra Hospital, SK8 2PX
- 17:00 - 20:00
- 0161 428 3656
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
I will always endeavour to fax a letter to your GP to initiate treatment by midday of the day following your appointment with me.
07557 105712 or 0161 428 3656